Evidence map›Paper›PMID 32737298›Full record

ArticleNature communications2020

Protein-responsive protein release of supramolecular/polymer hydrogel composite integrating enzyme activation systems.

Hajime Shigemitsu, Ryou Kubota, Keisuke Nakamura, Tomonobu Matsuzaki, Saori Minami, Takuma Aoyama, Kenji Urayama, Itaru Hamachi

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Stimuli-Responsive Supramolecular Biomaterials for Cancer Theranostics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  4. Review
  5. Hydrogel applications: a promising frontier in pneumonia therapy.Frontiers in bioengineering and biotechnology · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hajime Shigemitsu *Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Nishikyo-ku, Katsura, Kyoto, 615-8510, Japan.ORCID http://orcid.org/0000-0002-3104-049X
Ryou Kubota *Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Nishikyo-ku, Katsura, Kyoto, 615-8510, Japan.ORCID http://orcid.org/0000-0001-8112-8169
Keisuke NakamuraDepartment of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Nishikyo-ku, Katsura, Kyoto, 615-8510, Japan.ORCID http://orcid.org/0000-0003-0588-9374
Tomonobu MatsuzakiDepartment of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Nishikyo-ku, Katsura, Kyoto, 615-8510, Japan.
Saori MinamiDepartment of Macromolecular Science and Engineering, Kyoto Institute of Technology, Matsugasaki, Kyoto, 606-8585, Japan.
Takuma AoyamaDepartment of Macromolecular Science and Engineering, Kyoto Institute of Technology, Matsugasaki, Kyoto, 606-8585, Japan.
Kenji UrayamaDepartment of Macromolecular Science and Engineering, Kyoto Institute of Technology, Matsugasaki, Kyoto, 606-8585, Japan.ORCID http://orcid.org/0000-0002-2823-6344
Itaru HamachiDepartment of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Nishikyo-ku, Katsura, Kyoto, 615-8510, Japan. ihamachi@sbchem.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-3327-3916
Kyoto University · JPKyoto Institute of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-enzymatic proteins including antibodies function as biomarkers and are used as biopharmaceuticals in several diseases. Protein-responsive soft materials capable of the controlled release of drugs and proteins have potential for use in next-generation diagnosis and therapies. Here, we describe a supramolecular/agarose hydrogel composite that can release a protein in response to a non-enzymatic protein. A non-enzymatic protein-responsive system is developed by hybridization of an enzyme-sensitive supramolecular hydrogel with a protein-triggered enzyme activation set. In situ imaging shows that the supramolecular/agarose hydrogel composite consists of orthogonal domains of supramolecular fibers and agarose, which play distinct roles in protein entrapment and mechanical stiffness, respectively. Integrating the enzyme activation set with the composite allows for controlled release of the embedded RNase in response to an antibody. Such composite hydrogels would be promising as a matrix embedded in a body, which can autonomously release biopharmaceuticals by sensing biomarker proteins.

Indexed as

AnimalsAntibodiesAvidinBenzenesulfonamidesBiotinCarbonic Anhydrase IICarbonic Anhydrase InhibitorsCattleDelayed-Action PreparationsEnzyme ActivationHydrogelsPhase TransitionRheologyRibonucleasesSepharoseSulfonamidesAntibodiesAvidinBenzenesulfonamidesBiotinCarbonic Anhydrase IICarbonic Anhydrase InhibitorsDelayed-Action PreparationsHydrogelsRibonucleasesSepharoseSulfonamides

Identifiers

PMID32737298
PMCPMC7395795
OpenAlexW3046720110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.